AGATSA
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.0m | Early VC | ||
* | $1.6m | Early VC | |
* | INR300m | Late VC | |
Total Funding | CAD9.1m |
Related Content
Recent News about AGATSA
EditAgatsa is a MedTech company focused on providing innovative healthcare solutions to detect and manage cardiovascular diseases (CVDs) and diabetes. The company serves a diverse range of clients, including individual consumers, healthcare providers, and medical institutions. Operating in the healthcare technology market, Agatsa's core products include the world's smallest digital ECG device and a non-invasive glucose monitoring system. The business model revolves around selling these devices directly to consumers and healthcare providers, as well as offering subscription-based services for continuous health monitoring and data analytics. Revenue is generated through the sale of devices, subscription fees, and potentially through partnerships with healthcare institutions and insurance companies. Agatsa aims to bridge the gap between doctors and patients by making advanced healthcare services accessible and convenient.
Keywords: MedTech, digital ECG, non-invasive glucose monitoring, cardiovascular diseases, diabetes, healthcare technology, early detection, health monitoring, data analytics, subscription-based services.